產品編號
1087864
CAS 號
105816-06-6
中文名稱
順式-N-[[4-(1-甲基乙基)環己基]羰基]-D-苯丙氨酸
MDL 號
MFCD00875706
分子量
317.42
存儲條件
網頁展示純度為入庫指導純度值,各批次間存在一定差異,實際純度以收貨為準
熔點
沸點
閃點
旋光
描述
TPSA
66.4
LogP
3.2609
H_Acceptors
2
H_Donors
2
Rotatable_Bonds
6
[1]. Lauretta Maggi, et al. I. Technological approaches to improve the dissolution behavior of nateglinide, a lipophilic insoluble drug: nanoparticles and co-mixing. Int J Pharm. 2013 Sep 15;454(1):562-7.
[2]. Lauretta Maggi, et al. II. Technological approaches to improve the dissolution behavior of nateglinide, a lipophilic insoluble drug: co-milling. Int J Pharm. 2013 Sep 15;454(1):568-72.
[3]. Pratik Upadhyay, et al. Estimating relative stability of polymorphs by generation of configurational free energy phase diagram. J Pharm Sci. 2012 May;101(5):1843-51.
[4]. Roberto Latini, et al. Incidence of atrial fibrillation in a population with impaired glucose tolerance: the contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial. Am Heart J. 2013 Nov;166(5):935-40.e1.
[5]. Sajid Bashir, et al. Formulation and in vitro evaluation of nateglinide microspheres using HPMC and carbopol-940 polymers by ionic gelation method. Pak J Pharm Sci. 2013 Nov;26(6):1229-35.
警示圖
警示詞
Warning
危險申明
H302-H315-H319-H335
警告申明
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
GHS 編碼
GHS07
現貨供應
專業護航
售后無憂
品質保障
無需湊單